Open Account
Demo Account
About Us
Real-time Quotes & News
Market Analysis
Economic Calendar
Daily Market Analysis
Trading Platform
Platform Overview
How To Use
Terms
All Terms
Deposit & Withdrawal
Promotion
FAQ
Contact
繁
简
EN
User Login
Open Account
Demo Account
繁
简
EN
User Login
Open Account
Demo Account
About Us
About Aspire
Features of Aspire
Real-time Quotes & News
Real-time Quotes
Real-time News
Market Analysis
Economic Calendar
Market Analysis
Trading Platform
Meta Trader 5
Platform Features
Terms
All Terms
Deposit & Withdrawal
Promotion
FAQ
Contact
About Us
Terms
Metals Market
Trading Platform
Market Analysis
Promotion
FAQ
Contact
繁
简
EN
Nasdaq: As of the settlement date of December 31, the total short positions in all 5,169 Nasdaq-listed securities amounted to 18.57 billion shares.
2026-01-13
Nasdaq: As of the settlement date of December 31, the total short positions in all 5,169 Nasdaq-listed securities amounted to 18.57 billion shares.
Back
Other News
2026-01-13
Novo Nordisk (NVO.N) Executive Vice President of Product and Portfolio Strategy: The oral weight-loss drug market is larger than originally expected compared to the injectable market.
Novo Nordisk (NVO.N) Executive Vice President of Product and Portfolio Strategy: The oral weight-loss drug market is larger than originally expected compared to the injectable market.
2026-01-13
Novartis (NVS.N) CEO: Capital allocation priorities remain unchanged, and we will continue to make value-creating supplementary acquisitions.
Novartis (NVS.N) CEO: Capital allocation priorities remain unchanged, and we will continue to make value-creating supplementary acquisitions.
Chat with us
, powered by
LiveChat